Bridge in Hand, CFR Makes Adcock Bid

Bridge in Hand, CFR Makes Adcock Bid

Chile M&A Africa

Chile’s CFR Pharmaceuticals has formally bid ZAR12.6bn ($1.2bn) for South African drug maker Adcock Ingram, and has secured a $600m bridge loan to help, it says. CFR has support of shareholders holding 45% of Adcock, and claims letters of support from another 7.5%. It needs to reach 75% for success, and a pension fund holding 19% has come out against the deal. It would pay cash for 51.0%-64.2% of Adcock, and settle the rest with new CFR shares. The ZAR73.51 per share offer price represents a pre

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial